Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A curated listing of global health funding opportunities.

About

The following Horizon Europe/EDCTP3 calls are focused on sub-Saharan Africa. 

A. Research & Innovation Actions (RIA)

The 2026 Global Health EDCTP3 calls will support four RIA topics focused on tuberculosis, lower respiratory tract infections, HIV and climate-change-driven infectious diseases. 

  1. HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage: Global collaboration action towards better prevention, treatment and clinical management of HIV co-infections or co-morbidities in sub-Saharan Africa 

  2. HORIZON-JU-GH-EDCTP3-2026-01-LRTI-02-two-stage: Global collaboration action for prevention and treatment of Lower Respiratory Tract Infections in sub-Saharan Africa.  

  3. HORIZON-JU-GH-EDCTP3-2026-01-TB-01-two-stage: Global collaboration action for the development of TB drugs for therapy and chemoprophylaxis in adults and children in sub-Saharan Africa.  

  4. HORIZON-JU-GH-EDCTP3-2026-02-CH-01-two-stage: Global collaboration action on climate and health in sub-Saharan Africa. 

Amount and Deadline

Funding: €5 million – €10 million per project 
Deadline: 4 March 2026 (first stage) 
Calls are expected to open by mid-January 2026

B. Coordination and support action (CSA) calls

Two CSA calls will support training and capacity development in sub-Saharan Africa:

  1. HORIZON-JU-GH-EDCTP3-2026-03-SERP-01: Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms.  

  2. HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02: Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence.  

Amount and deadline

Funding: €1.5 million – €2.25 million per project 

Deadline: 31 August 2026 (later deadline; single-stage call, forecast)

Eligibility

Country of applicant institution: Albania, Armenia, Bosnia and Herzegovina, Egypt, European Union (EU), Faroe Islands, Georgia, Republic of, Iceland, Israel, Kosovo, Moldova, Republic of, Montenegro, New Zealand, North Macedonia, Norway, Serbia, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom.

 

For more information see the HORIZON website

About 

This fund provides single-step support for developing a new or repurposed medicine, medical device, diagnostic, or other medical product. Projects should focus on a high-risk development step, supported by prior funding, to generate critical data that either de-risks further progression or confirms failure. 

criteria

  • Award range: £50,000 - £300,000
  • Deadline: 11 March 2026, 4pm UK time
  • Eligibility: you must be based at a research organisation eligible for Medical Research Council (MRC) funding

 

Apply for the MRC Gap fund for single-step support for medical product development

 

These awards will support transdisciplinary teams to catalyse research discoveries at the intersection of genomics, humanities, social sciences and bioethics. Funded projects will be given the time and resources to create new research agendas and explore innovative ways of working. 

Criteria

Funding duration: 12-24 months 

Funding amount: Up to £500,000 for each award 

Eligibility: early-, mid- and established researchers 

Co-applicants are required. 

Find out more and apply.

About

This scheme supports academic-led translational projects to develop and test novel therapeutics, medical devices, diagnostics, or other interventions. Projects should aim to improve prevention, diagnosis, prognosis, or treatment of significant health needs, or develop research tools that increase the efficiency of intervention development. 

Criteria

  • Total fund: £11,000,000 
  • Deadline: 18 March 2026, 4:00pm UK time 
  • Criteria: employment at a research organisation eligible for MRC funding. 

Apply to the MRC: Developmental Pathway Funding scheme

This scheme funds transdisciplinary teams to make the impacts of climate change on physical and mental health visible to drive climate policy action at scale. 

Criteria

  • Applications open to mid and established researchers 
  • Funding amount: Up to £2.5 million per award 
  • Funding duration: Up to 3 years 
  • Co-applicantsRequired 

Webinar

Join the webinar to learn more: 23 February 2026 at 12:00 GMT 

Find out more and apply

 

ABOUT

Wellcome is funding the establishment of five global evidence synthesis infrastructure hubs to strengthen timelyrelevant and affordable evidence synthesis in low- and middle-income countries (LMICs). Hubs will use AI-enabled methods to support health research and policy and must align with at least one priority area (Climate and Health, Infectious Disease, Mental Health or Discovery Research) and one policy sector, such as food systems, humanitarian assistance, economic growth, peace and effective institutions, or social protection.

AMOUNT

£1.5 million-£1.9 million per hub over 3-5 years 

ELIGIBILITY

Lead applicants must be based at eligible organisations in LMICs (excluding mainland China)

Find out more and apply

To honour Paul Farmer's memory, the McGill School of Population and Global Health has created a lectureship and award that will be given, on an annual basis, to an individual who models and demonstrates Paul’s vision of a ‘preferential option for the poor’ to achieve equity in health. In particular, the award will be used to honour individuals (or couples) working in under-served communities whose work is often not recognized or made visible. 

Deadline

Amended deadline: This opportunity will be available soon. The next call is expected to open in spring 2026. 

ABOUT

The CAP Foundation’s Global Pathology Development Grant supports international projects that strengthen and expand pathology services in low-resourced settings. Funding is aimed at sustainable, high-impact initiatives across education and training, patient care, laboratory quality, and diagnostic technologies. 

AMOUNT

FundingUp to USD 10,000 

ELIGIBILITY

Open to pathologists and laboratory professionals seeking to develop or expand pathology services in low-resource settings globally. Projects must demonstrate clear collaboration with a partner institution in the country where the work will take place. The scheme is not restricted to US citizens; international applicants are eligible in line with the foundation’s requirements.

CAP membership is preferred but not mandatory.

Find out more and apply

About

The Discovery Research programme provides funding for early-career researchers from any discipline who are ready to develop their research identity. Through innovative projects, they will deliver shifts in understanding related to human life, health and wellbeing. By the end of the award, they will be ready to lead their own independent research programme.  

criteria 

  • Funding amount: salary and up to £400,000 for research expenses. 
  • Funding duration: Usually 5 years (but may be less for some disciplines) 

 

 

Find out more and apply